Stock Market Reviews

Read and share opinions on SER (Serina Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market

Latest News

• Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
  Nov 13, 2025
• Serina Therapeutics Provides Regulatory Update on SER-252 Program
  Nov 3, 2025
• Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement with Patients, Clinicians, and Investors
  Oct 8, 2025
• Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease
  Oct 6, 2025
• Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson’s Disease
  Sep 9, 2025
• Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
  Sep 8, 2025
• Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson’s Disease under 505(b)(2) NDA Pathway
  Aug 25, 2025
• Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights
  Aug 11, 2025
• Serina Therapeutics Advances POZ-VMAT2i into Development for Tardive Dyskinesia (TD)
  Jul 29, 2025
• Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference
  Jul 28, 2025
• Serina Therapeutics Makes Grant to New Employee Under Inducement Plan
  Jul 10, 2025
• Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting
  Jul 1, 2025
• Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025
  Jun 23, 2025
• UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42
  Jun 18, 2025
• Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42
  Jun 17, 2025
• Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event "Is the Beaten Down Biotech Sector the Smartest Bet in Today's Volatile Market?"
  Jun 9, 2025
• Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors
  May 22, 2025
• Serina Therapeutics Makes Grants to New Employees Under Inducement Plan
  May 14, 2025